Full Press Release Details
Prana Biotechnology Limited (ASX:
The securities of Prana Biotechnology Limited
( PBT') will be placed in trading halt at the request of PBT, pending it releasing an announcement. Unless ASX decides
otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Friday, 28 December
2018 or when the announcement is released to the market.
Adviser, Listings Compliance (Melbourne)
| 24 December 2018 | Market Announcement 1/1 |
| ASX Limited | ASX Customer Service Centre 131 279 | asx.com.au |
Monday 24 December 2018
Adviser, Listings Compliance (Melbourne)
ASX Compliance Pty Limited
Level 4, North Tower
Rialto Towers, 525 Collins Street
| By email only: | cheng.tang@asx.com.au |
| tradinghaltsmelbourne@asx.com.au |
REQUEST FOR TRADING HALT
Prana Biotechnology Limited
(ASX: PBT) (the Company) requests an immediate halt to the trading of the Company's ordinary shares quoted on the
Australian Securities Exchange (ASX) in accordance with ASX Listing Rule 17.1.
The trading halt is requested pending an announcement
to be made by the Company to the market in relation to a proposed capital raising ("purpose").
In accordance with ASX Listing Rule 17.1, the Company
provides the following information in relation to the request:
Please contact me if you require any further information
concerning this matter.
PRANA BIOTECHNOLOGY LIMITED
Biotechnology Limited
3, 460 Bourke Street, Melbourne, VIC 3000 Australia
+61 (0)3 9349 4906 | WWW.pranabio.com